Black Patients, Psoriasis, and Biologic Agents
Rates of biologic agent use in minority patients with psoriasis compared with White patients were determined in this study.
Rates of biologic agent use in minority patients with psoriasis compared with White patients were determined in this study.
The phenotype characteristics that best describe children flaring during pollen season were investigated.
Valerie Harvey, MD and Lynn McKinley-Grant, MD explain the importance of diversity and specialized training to treat patients with skin of color in the field of dermatology.
The study’s goal was to compare the clinical efficacy, safety, tolerability, and improvement in QOL index of three peeling agents for patients with melasma.
The prevalence and patterns of cutaneous manifestations in COVID-19 in patients with skin of color is reported.
Adjusted excess all-cause mortality in April 2020 varied by race/ethnicity and by state.
A summary of tips for capturing high quality images of patients with skin of color is provided.
The differences in incidence, clinical features, genetics, treatment and outcome, in cutaneous melanoma in White vs people of African descent populations is reviewed.
Mental health conditions and substance use are common during the COVID-19 pandemic, especially among racial- and ethnic-minority groups.
Data surrounding the association of UV exposure and risk for cutaneous melanoma in patients with skin of color was assessed.